Article thumbnail

Cardiac autonomic neuropathy in patients with diabetes and no symptoms of coronary artery disease: comparison of 123I-metaiodobenzylguanidine myocardial scintigraphy and heart rate variability

By Arthur J. H. A. Scholte, Joanne D. Schuijf, Victoria Delgado, Jurriaan A. Kok, Mieke T. J. Bus, Arie C. Maan, Marcel P. Stokkel, Antje V. Kharagitsingh, Petra Dibbets-Schneider, Ernst E. van der Wall and Jeroen J. Bax
Topics: Original Article
Publisher: Springer-Verlag
OAI identifier: oai:pubmedcentral.nih.gov:2918794
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. Abdominal visceral fat accumulation is associated with the results of (123)I-metaiodobenzylguanidine myocardial scintigraphy in type 2 diabetic patients.
  2. (2010). and treatment. Diabetes Metab Rev 1994;10:339–83.
  3. (1992). Assessment of cardiovascular autonomic function: age-related normal ranges and reproducibility of spectral analysis, vector analysis, and standard tests of heart rate variation and blood pressure responses. Diabet Med
  4. (1980). Assessment of cardiovascular effects in diabetic autonomic neuropathy and prognostic implications.
  5. Association. Diagnosis and classification of diabetes mellitus.
  6. (2006). Brain natriuretic peptide and cardiac autonomic function in type 2 diabetic patients. Diabetes Res Clin Pract
  7. (2008). Cardiac autonomic diabetic neuropathy. Diab Vasc Dis Res
  8. Cardiac autonomic neuropathy in the diabetic patient: does 123I-MIBG imaging have a role to play in early diagnosis?
  9. Cardiac sympathetic dysfunction correlates with abnormal myocardial contractile reserve in dilated cardiomyopathy patients.
  10. Cardiac sympathetic dysinnervation in type 2 diabetes mellitus with and without ECG-based cardiac autonomic neuropathy.
  11. Cardiovascular autonomic neuropathy due to diabetes mellitus: clinical manifestations, consequences, and treatment.
  12. Cardiovascular survey methods. Monogr Ser World Health Organ 1968;56:1–188.
  13. (1996). Demonstration of regional sympathetic denervation of the heart in diabetes.
  14. (2004). Detection of silent myocardial ischemia in asymptomatic diabetic subjects: the DIAD study. Diabetes Care
  15. Diabetic autonomic neuropathy.
  16. (2003). Diabetic autonomic neuropathy. Diabetes Care
  17. (1999). Diabetic cardiac autonomic dysfunction: parasympathetic versus sympathetic. Ann Nucl Med
  18. (2007). Diabetic cardiovascular autonomic neuropathy. Circulation
  19. Diagnosis and management of diabetic autonomic neuropathy.
  20. Different manifestations of coronary artery disease by stress SPECT myocardial perfusion imaging, coronary calcium scoring, and multislice CT coronary angiography in asymptomatic patients with type 2 diabetes mellitus.
  21. (1997). Effect of chronic quinapril administration on heart rate variability in patients with diabetic autonomic neuropathy. Diabetes Care
  22. Effect of essential hypertension on cardiac autonomic function in type 2 diabetic patients.
  23. (1998). Effect of glycaemic control on myocardial sympathetic innervation assessed by [123I]metaiodobenzylguanidine scintigraphy: a 4-year prospective study in IDDM patients. Diabetologia
  24. (1997). Effects of physical training on heart rate variability in diabetic patients with various degrees of cardiovascular autonomic neuropathy. Cardiovasc Res
  25. (2004). Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care
  26. (2004). Heart rate variability: a noninvasive electrocardiographic method to measure the autonomic nervous system. Swiss Med Wkly
  27. (2005). High-sensitivity C-reactive protein is associated with insulin resistance and cardiovascular autonomic dysfunction in type 2 diabetic patients. Metabolism
  28. Homocysteine levels are associated with the results of 123I-metaiodobenzylguanidine myocardial scintigraphy in type 2 diabetic patients.
  29. (2001). Impaired autonomic function is associated with increased mortality, especially in subjects with diabetes, hypertension, or a history of cardiovascular disease: the Hoorn Study. Diabetes Care
  30. Iskandrian AE. MIBG imaging.
  31. (1998). Long-term effect of converting enzyme inhibition on circadian sympathetic and parasympathetic modulation in patients with diabetic autonomic neuropathy. Acta Cardiol
  32. (2004). Low heart rate variability is a risk factor for sudden cardiac death in type 2 diabetes. Diabetes Res Clin Pract
  33. (1995). Metaiodobenzylguanidine imaging in diabetes mellitus: assessment of cardiac sympathetic denervation and its relation to autonomic dysfunction and silent myocardial ischemia.
  34. Microcomputer-based measurement of beat-to-beat intervals and analysis of heart rate variability. Med Prog Technol 1981;8:77–82.
  35. (1998). Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction.
  36. Mortality in diabetic autonomic neuropathy. Lancet 1976;1:601–3.
  37. (1995). Myocardial iodine-labeled metaiodobenzylguanidine 123 uptake relates to age.
  38. Normal values and within-subject variability of cardiac I-123 MIBG scintigraphy in healthy individuals: implications for clinical studies.
  39. of Nuclear Cardiology. Imaging guidelines for nuclear cardiology procedures. doi: http://www.asnc.org/ section_73.cfm.
  40. (1997). Partial restoration of scintigraphically assessed cardiac sympathetic denervation in newly diagnosed patients with insulindependent (type 1) diabetes mellitus at one-year follow-up. Diabet Med
  41. (2001). Predictive value of cardiac autonomic neuropathy in diabetic patients with or without silent myocardial ischemia. Diabetes Care
  42. (2002). Prevalence of myocardial viability assessed by single photon emission computed tomography in patients with chronic ischaemic left ventricular dysfunction. Heart
  43. Prognostic value of cardiac I-123 metaiodobenzylguanidine imaging in patients with non-insulin-dependent diabetes mellitus.
  44. Prognostic value of serial cardiac 123I-MIBG imaging in patients with stabilized chronic heart failure and reduced left ventricular ejection fraction.
  45. (1996). Reduced myocardial 123I-metaiodobenzylguanidine uptake in newly diagnosed IDDM patients. Diabetes
  46. (1996). Regional abnormality of iodine-123-MIBG in diabetic hearts.
  47. Respiratory influence on heart rate in diabetes mellitus. Br Med J 1979;1:924–5. 1704 Eur J Nucl Med Mol Imaging (2010) 37:1698–170520. Levin AB. A simple test of cardiac function based upon the heart rate changes induced by the Valsalva maneuver.
  48. (1995). Scintigraphic evidence for cardiac sympathetic dysinnervation in long-term IDDM patients with and without ECG-based autonomic neuropathy. Diabetologia
  49. (1977). Self-administration of a questionnaire on chest pain and intermittent claudication.
  50. Smoking is associated with insulin resistance and cardiovascular autonomic dysfunction in type 2 diabetic patients.
  51. (1998). Sudden cardiac death. Circulation